Transaction · 0001415889-25-006233

Russell Steven Jon

Russell Steven Jon, CMO, reported a transaction classified as grant at Beta Bionics, Inc. involving 52000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 52000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
BBNXBeta Bionics, Inc.
Filing timeMar 03
Trade dateFeb 27, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

BBNX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BBNX since 2025-03-03Filed 550 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001415889-25-006233
Employee Stock Option (right to buy)
Transaction date
Feb 27, 2025
Filed Mar 03, 2025, 10:45 PM · 4d delay
Shares
52.0k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
52.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.

  2. F2

    The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025.

Original filing · 0001415889-25-006233
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BBNX